USDM Life Sciences

10/12/2026

We’re headed to Boston! USDM is a Platinum Sponsor at Veeva R&D and Quality Summit 2026, October 20–21.

With 425+ Veeva projects delivered, we help R&D and Quality teams:
✅ Bring Veeva AI into regulated work with the right governance and validation
✅ Keep Vault programs running smoothly after go-live
✅ Stay inspection-ready across Quality, Regulatory, Safety, and Clinical

Let’s connect at Summit. Book time with our team: https://www.usdm.com/resources/news-events/veeva-rd-quality-summit-2026-usdm-sponsor

USDM is a Platinum sponsor at Veeva R&D and Quality Summit 2026, where life sciences R&D, Quality, Regulatory, Safety, Clinical, and IT leaders gather to advance Veeva programs and regulated operations.

10/09/2026

Your board won’t ask how many AI pilots you launched. They’ll ask if your program can survive scrutiny.

Get the CxO Guide to Sustainable AI → https://www.usdm.com/resources/white-papers/cxo-guide-sustainable-ai

10/08/2026

AI agents are moving closer to your regulated content. Is your Box environment ready?

USDM is a proud sponsor of , Nov 5–6 in San Francisco. Stop by our booth to talk governed Box adoption, validated content operations, and inspection-ready AI workflows for life sciences.

Book time with our team:

Meet USDM, a BoxWorks Sponsor at BoxWorks 2026, in San Francisco. Stop by our booth during the event to meet the team and discuss governed Box adoption, validated content operations, and inspection-ready AI workflows for life sciences.

10/08/2026

85% of organizations are adopting AI agents. Only 5% have scaled them to production.

That gap is where the risk lives. Agents don't follow rules, they pursue goals, so they need owners, oversight, and governance built in from day one.

Read what RSA 2026 revealed → https://usdm.com/resources/blogs/agents-without-owners-what-rsa-2026-revealed-about-the-agentic-ai-governance-gap

10/07/2026

70–80% of AI pilots never reach production. In GxP environments, governance is usually the missing piece.

USDM's new white paper lays out an enterprise AI governance framework for life sciences, covering the AI lifecycle, partner-platform AI risk, vendor assessment, and a 90-day path to a governance baseline.

Download it:

White paper: Download USDM's AI governance for life sciences white paper for an enterprise framework covering GxP AI governance, vendor risk, lifecycle controls, and compliant AI adoption.

10/07/2026

Boston Scientific. Stryker. Novo Nordisk. Amgen. Four of the biggest names in life sciences — all disclosed cyber incidents in 2026.
Orders disrupted. Clinical data at risk. Patient information exposed. Third-party systems pulled in too.
Here's the thing: prevention isn't a resilience strategy. The real question isn't whether attackers get in — it's whether your business keeps running when they do.

USDM breaks down what 2026's cyber incidents are revealing about life sciences risk.
Read the analysis → https://www.usdm.com/resources/blogs/boston-scientific-cyber-incident-life-sciences-risk

10/06/2026

Join USDM's Brittany Walker at CDISC US Interchange 2026 in Denver to see how a governed, Glean-powered TMF intake pipeline helps teams

✅ Improve completeness across disparate systems
✅ Find evidence faster
✅ Reduce manual review burden
✅ Stay inspection-ready

Tues, Oct 6 | 11:00–11:30 AM | Session 6E, Evergreen E

Can't make the session? Request a meeting with USDM:

Meet USDM at CDISC US Interchange 2026 in Denver and hear Brittany Walker present on enterprise AI in TMF management, governance, confidence, and compliance.

10/06/2026

Paper-based processes don't belong in modern life sciences.
USDM modernizes pharma, biotech, and medical device teams with paperless validation, digital quality systems, and validated cloud migration — without losing compliance control.
Start your modernization roadmap → https://www.usdm.com/resources/webinars/usdm-life-sciences-summit-2025-b

10/05/2026

Token prices are falling, so why is your AI bill going up?

Reasoning models and agents use more tokens per task, and validation costs rarely make it into the business case. Stress-test your ROI at 2x, 3x, and 5x spend before your board does.

Blog post: A board-ready AI ROI stress test for life sciences leaders using five-layer TCO, persona-based consumption forecasting, and model-agnostic architecture.

10/02/2026

Your AI pilot worked. Will it survive scale, inspection, and the next pricing change?

USDM's CxO Guide to Sustainable AI gives life sciences leaders a practical framework to scale AI that stays compliant, cost-resilient, and inspection-ready:

✅ Risk zones to classify AI by GxP impact
✅ Validation that's scaled to risk, so you don't over-validate
✅ A five-layer TCO model to keep costs predictable
✅ A 90-day path to governed production

Governance isn't the brake. It's what makes AI scale.

Download the guide:

White paper: Governance, Validation, Architecture, and Cost Resilience in Regulated Life Sciences - a strategic framework for CEOs, CIOs, CTOs, CCOs, and VP Regulatory Affairs.